Loading...
Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH
Cisplatin-based chemotherapy is the standard treatment for non-small cell lung cancer (NSCLC). However, drug resistance emergences after treatment. Long non-coding RNA microvascular invasion in hepatic cancer (MVIH) plays an important role in drug resistance in a variety of cancers. This study inves...
Na minha lista:
| Udgivet i: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959054/ https://ncbi.nlm.nih.gov/pubmed/31942179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.35792 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|